https://adisinsight.springer.com/trials/700296554?error=cookies_not_supported&code=03df8199-c46c-4f55-8e12-0908c97cc354
Phase I Study of Mirvetuximab Soravtansine (IMGN853) and Rucaparib for Recurrent Endometrial,...
This phase I trial study aims to determine the recommended phase II dose (RPTD), safety and tolerability and to explore the objective antitumor activity
phase i study